Clinical Effects for Patients with Recurrent Advanced Non-small Cell Lung Cancer Treated with Icotinib Hydrochloride

Clinical Effects for Patients with Recurrent Advanced Non-small Cell Lung Cancer Treated with Icotinib Hydrochloride

Background and objective Icotinib hydrochloride is the third single target EGFR-TKI used in clinical treatment of advanced non-small cell lung cancer (NSCLC). Clinical research reports on its efficacy and survival in patients with Recurrent Advanced NSCLC are still little.The aim of this study is to...

Full description

Bibliographic Details
Main Authors: Jingying NONG, Na QIN, Jinghui WANG, Xinjie YANG, Hui ZHANG, Yuhua WU, Jialin LV, Quan ZHANG, Shucai ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
Icotinib
Lung neoplasms
Efficacy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2013.05.05

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2013.05.05

Similar Items